Kalazar Detect Rapid Test

Introducing the Kalazar Detect™ Rapid Test, a state-of-the-art diagnostic tool specifically designed for the qualitative detection of Visceral Leishmaniasis, commonly known as Kalazar or Kala-azar. This innovative test offers rapid and accurate results, aiding healthcare professionals in the timely diagnosis and management of this debilitating disease.

The Kalazar Detect™ Rapid Test employs a lateral flow chromatographic immunoassay method to detect specific antibodies associated with Visceral Leishmaniasis in human serum, plasma, or whole blood samples. The test provides results within minutes, making it highly suitable for point-of-care testing in healthcare facilities and field settings.

With exceptional sensitivity and specificity, the Kalazar Detect™ Rapid Test minimizes the risk of false-positive or false-negative results, ensuring reliable diagnostic outcomes. This enables healthcare providers to initiate appropriate treatment and preventive measures for individuals affected by Visceral Leishmaniasis promptly.

The test’s user-friendly design, clear result interpretation, and rapid turnaround time make it an invaluable tool for screening, diagnosis, and surveillance of Visceral Leishmaniasis in endemic regions. It plays a crucial role in public health efforts to control and eliminate this disease, ultimately improving patient outcomes and reducing disease burden.